Seòmar agus comataidhean

Details of transfrontier shipments of waste are not published or held by Scottish Government, but are held by SEPA.

Information on exports to other UK countries is not available for the years requested.

Due to the cyber attack suffered by SEPA in 2020, data for that year is unavailable. The 2021 data is expected to be available from 28 March 2023, following publication of official statistics on Waste from All Sources. SEPA does not yet have a complete dataset for 2022, as returns are still being processed.

SEPA’s Waste from All Sources Discover Tool is available here: Waste (from all sources) (sepa.org.uk)

That information is not available for the years requested.

Due to the cyber attack suffered by SEPA in 2020, data for that year is unavailable. The 2021 data is expected to be available from 28 March 2023, following publication of official statistics on Waste from All Sources. SEPA does not yet have a complete dataset for 2022, as returns are still being processed.

SEPA’s Waste from All Sources Discover Tool is available here: Waste (from all sources) (sepa.org.uk)

Details of transfrontier shipments of waste are not published or held by Scottish Government, but are held by SEPA.

Information on exports to other UK countries is not available for the years requested.

Due to the cyber attack suffered by SEPA in 2020, data for that year is unavailable. The 2021 data is expected to be available from 28 March 2023, following publication of official statistics on Waste from All Sources. SEPA does not yet have a complete dataset for 2022, as returns are still being processed.

SEPA’s Waste from All Sources Discover Tool is available here: Waste (from all sources) (sepa.org.uk)

The Scottish Government has been following the process for excluding the deposit return scheme regulations from the Internal Market Act 2020 and we expect a decision from the UK Government as soon as possible.

We are aware of the serious negative impact this condition can have on people’s lives and therefore it is important that access to treatment and support is timely. We want to ensure that people have informed conversations with their GP in order to support the diagnosis of lipoedema.

We have now finalised the new NHS Inform webpage on Lipoedema . The new resource aims to provide people with consistent, reliable and accessible information empowering them to make informed decisions about their health and includes information on the symptoms, causes, self-management and treatment options.

We will continue to work with organisations such as Talk Lipoedema to find ways to raise awareness of the condition and its symptoms.

In March 2022, the National Institute for Health and Care Excellence’s (NICE) Interventional Procedures Advisory Committee did a rapid review on the available evidence on the safety and efficacy of liposuction as treatment for lipoedema and found it to be inadequate. The recommendation was for the procedure to only be carried out in the context of research.

Previously, NHS Tayside was the only Health Board to provide liposuction as a treatment for lipoedema. Due to the updated guidance, NHS Tayside have stopped liposuction as a treatment option until NICE reviews its guidelines in 2025 after further evidence and research has been undertaken.

There are currently non-surgical treatment options for lipoedema and those with the condition will be treated by healthcare professionals at primary care level and, where appropriate, referred to specialist services in secondary care. Any particular treatment is at the discretion of the lead clinician. It is NHS Boards and healthcare professionals locally who have responsibility for service delivery and patient treatment.

The Scottish Government released information regarding Circularity Scotland’s application to Scottish Ministers to become a scheme administrator for Scotland’s Deposit Return Scheme, in response to an information request under the Environmental Information (Scotland) Regulations 2004. The information released in response to that request was published on the Scottish Government website on 22 January 2022 under reference FOI/202200276068.

Circularity Scotland, as the scheme administrator for DRS, represents and provides services to its members including drinks producers, importers, wholesalers and retailers. Scottish Ministers, Scottish Government officials and Circularity Scotland regularly meet with stakeholders including representatives of small producers and that package of support was in direct response to concerns they have raised.

In Scotland, the Scottish Medicines Consortium (SMC) appraises the clinical and cost-effectiveness of newly-licensed medicines. Following a full submission from the submitting company, Merck Sharp & Dohme Ltd, the SMC published “accepted for restricted use” advice for Health Boards on the routine use of Keytruda ® for the treatment of persistent, recurrent, or secondary cervical cancer in NHS Scotland on 13 February 2023.

The decision to prescribe a medicine for an individual, and which medicine to prescribe, is entirely for the clinician in charge of an individual’s care, having taken into account their clinical condition, safety considerations and any relevant clinical guidance.

We will publish an update on each of the accepted Deer Working Group recommendations, alongside minutes from the December meeting of the Deer Management Strategic Board shortly. This will be available, alongside minutes of previous meetings, on the Board’s webpages here: Deer Management Strategic Board - gov.scot (www.gov.scot) .

The Biodiversity Strategy is not the primary vehicle for addressing biosecurity issues, although clearly there are related issues and impacts which stress the need to mainstream biodiversity across the full range of Scottish Government policy.

The Biodiversity Strategy sets out a long-term, high-level ambition and Vision for 2045. Delivering that Vision is supported by a series of Outcomes across a range of overlapping ecosystems and land use types.

The Strategy also includes 33 Priority Actions which include, of relevance to the question:

• Implement Scottish Plan for INNS surveillance, prevention and control, and secure wider support measures to enable effective INNS removal
• Support surveillance and monitoring to support managing risks around pathogens and disease in wild bird populations
• Develop a Biodiversity Investment Plan to direct how we address the Finance Gap for nature
• Maintain and seek to increase investment in nature restoration through our £65 million Nature Restoration Fund.

A Delivery Plan is now being developed jointly by Scottish Government and NatureScot officials, drawing on engagement from key policy areas and across a wider network which includes expert academic input alongside significant stakeholder engagement.

Each iteration of the Delivery Plan will include estimated costs and will be reviewed in light of monitoring data to demonstrate the impact of actions taken so far.

The Biodiversity Investment Plan will direct how we address the finance gap for nature. It will ensure that investment is strategic, planned and focused on agreed priorities and will assist in securing responsible private investment in Scotland’s natural capital funding.